Organicell Regenerative Medicine
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Organicell Regenerative Medicine generated cash of -$1,812,499, which is less than the previous year. Cash used in financing activities reached the amount of $2,409,433 last year. Net change in cash is therefore $458,240.
Cash Flow
| 2012 | -8.74K | 0 | 0 |
|---|---|---|---|
| 2013 | -29.95K | 0 | 42K |
| 2014 | -64.73K | 0 | 46.81K |
| 2015 | -384.79K | -7.90K | 491.74K |
| 2016 | -548.18K | -20.13K | 556.97K |
| 2017 | -881.52K | -45.13K | 940K |
| 2018 | -511.99K | 95.45K | 420K |
| 2019 | -565.45K | -32.73K | 687.73K |
| 2020 | -1.81M | -138.69K | 2.40M |
BPSR Cash Flow Statement (2012 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 132.55K | 43.01K | 39.56K | 26.22K | 37.56K | 244 | 15.94K | 2.32K | 12.07K |
Operating activities | |||||||||
Net income | -12.58M | -1.73M | -3.46M | -8.97M | -1.25M | -738.35K | -65.81K | -32.17K | -12.33K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 36.77K | 14.79K | 7.83K | 19.31K | 345 | 86 | 0 | 0 | 0 |
Stock-based compensation expense | 9.91M | 727.41K | 4.02M | 5.82M | 0 | 268K | 0 | 0 | 0 |
| Deferred income tax benefit | 9.91M | 727.41K | 4.02M | 5.82M | 0 | 268K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -3.69K | 11.35K | 4.69K | -119.08K | 18.25K | 44.51K | 2.04K | -9.18K | 0 |
Inventories | -68.84K | -77.96K | 60.31K | -109.61K | -9.94K | -1.60K | 5.83K | -297 | -7.54K |
Accounts payable | 218.75K | 75.58K | 64.78K | 343.35K | 5.24K | 9.35K | -19.21K | 9.54K | 11.13K |
Cash generated by operating activities | -1.81M | -565.45K | -511.99K | -881.52K | -548.18K | -384.79K | -64.73K | -29.95K | -8.74K |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -138.69K | -32.73B | -4.56K | -45.13K | -26.31K | -7.90K | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 100.02K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -138.69K | -32.73K | 95.45K | -45.13K | -20.13K | -7.90K | 0 | 0 | 0 |
Financing activities | |||||||||
Common Stock Issued | 2.19M | 459.5K | 100K | 505K | 457.27K | 496.2K | 0 | 42K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -185.88K | 0 | 0 | 0 | -300 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 2.40M | 687.73K | 420K | 940K | 556.97K | 491.74K | 46.81K | 42K | 0 |
Net Change In Cash | 458.24K | 89.54K | 3.45K | 13.33K | -11.34K | 99.05K | -15.70K | 13.61K | -9.74K |
Cash at end of period | 590.79K | 132.55K | 43.01K | 39.56K | 26.22K | 99.29K | 244 | 15.94K | 2.32K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |